These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8830959)

  • 1. Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients.
    Loven DP; James JF; Biggs L; Little KY
    Biol Psychiatry; 1996 Aug; 40(3):230-2. PubMed ID: 8830959
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
    Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
    Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
    Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
    Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agranulocytosis in the course of phenothiazine therapy: case reports.
    Yassa R
    J Clin Psychiatry; 1985 Aug; 46(8):341-3. PubMed ID: 2862136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes in the interaction of the brain hemispheres in the course of drug therapy of psychosis].
    Ivanov OV
    Zh Evol Biokhim Fiziol; 2003; 39(1):104-9. PubMed ID: 12739274
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocyte superoxide dismutase (eSOD) determination in positive moments of psychosis].
    Vaiva G; Thomas P; Leroux JM; Cottencin O; Dutoit D; Erb F; Goudemand M
    Therapie; 1994; 49(4):343-8. PubMed ID: 7878602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.
    Stip E; Mancini-Marïe A; Letourneau G; Fahim C; Mensour B; Crivello F; Dollfus S
    Int Clin Psychopharmacol; 2009 Jan; 24(1):34-41. PubMed ID: 19077676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia.
    Bär KJ; Wernich K; Boettger S; Cordes J; Boettger MK; Löffler S; Kornischka J; Agelink MW
    Psychiatry Res; 2008 Jan; 157(1-3):255-7. PubMed ID: 17919737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of various graphometric methods in the evaluation of the neuroleptic threshold].
    Pobocha J
    Ann Acad Med Stetin; 1978; 24():549-64. PubMed ID: 33585
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement in refractory psychosis with dronabinol: four case reports.
    Schwarcz G; Karajgi B
    J Clin Psychiatry; 2010 Nov; 71(11):1552-3. PubMed ID: 21114952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].
    Gałecki P; Pietras T; Florkowki A
    Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of neuroleptics on the frontal functions of schizophrenics].
    Verdoux H; Magnin E; Bourgeois M
    Ann Med Psychol (Paris); 1994 Oct; 152(8):530-4. PubMed ID: 7818228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
    Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia.
    Reske M; Kellermann T; Habel U; Jon Shah N; Backes V; von Wilmsdorff M; Stöcker T; Gaebel W; Schneider F
    J Psychiatr Res; 2007 Dec; 41(11):918-27. PubMed ID: 17467008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.